The U.S. hormone therapy market is expanding due to rising healthcare costs, an aging population, and patient-centered care trends favoring home-based treatments. Opportunities include user-friendly ...

Growth hormone receptor (GHR) signaling in bladder cancer is associated with advanced tumor stages and poor survival outcomes. High GHR expression in tumors up-regulates genes involved in drug ...

More Americans are turning to peptides for muscle building, skin rejuvenation, and to try and live longer even though the ...

Q3 2025 revenue of €143.1 million for YORVIPATH® and €50.7 million for SKYTROFA®– Q3 2025 operating profit of €11.0 million– TransCon® ...

Peptide stacking has potential in regenerative and longevity medicine, but using unregulated or poorly studied peptides is ...

Ascendis Pharma’s consensus analyst price target has recently increased from $245.61 to $258.77 per share. This reflects a renewed sense of optimism as Yorvipath’s uptake accelerates and real-world ...

Lucy D. Mastrandrea, professor of pediatrics in the Jacobs School of Medicine and Biomedical Sciences, has been elected to ...

Poor sleep quality may be a major overlooked risk factor when it comes to running injuries. Afternoon naps could help.

No evidence that drinking urine has health benefits, could make health issues worseIN SHORT: A Facebook reel claims that drinking urine helps reabsorb important chemicals that the body lost in the ...

Lucy D. Mastrandrea, MD, PhD, professor of pediatrics, has been elected to membership in the American Pediatric Society.